Koninklijke DSM (OTCMKTS:RDSMY – Get Rating) has earned an average recommendation of “Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $177.75.
Several equities analysts recently issued reports on the company. Barclays cut their target price on Koninklijke DSM from €193.00 ($203.16) to €189.00 ($198.95) in a research report on Tuesday, March 29th. Morgan Stanley cut their target price on Koninklijke DSM from €166.00 ($174.74) to €155.00 ($163.16) and set an “equal weight” rating on the stock in a research report on Monday, March 28th. Zacks Investment Research raised Koninklijke DSM from a “sell” rating to a “hold” rating in a research report on Tuesday, February 15th. UBS Group cut their price target on Koninklijke DSM from €190.00 ($200.00) to €185.00 ($194.74) and set a “buy” rating on the stock in a research report on Thursday, March 31st. Finally, Credit Suisse Group cut their price target on Koninklijke DSM from €205.00 ($215.79) to €182.00 ($191.58) and set an “outperform” rating on the stock in a research report on Thursday, February 17th.
OTCMKTS RDSMY opened at $36.90 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.52 and a quick ratio of 1.58. The stock’s fifty day moving average price is $42.30 and its 200 day moving average price is $48.42. Koninklijke DSM has a 1 year low of $36.22 and a 1 year high of $56.92.
About Koninklijke DSM (Get Rating)
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.
- Get a free copy of the StockNews.com research report on Koninklijke DSM (RDSMY)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.